Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

3GAX

Crystal structure of monomeric human cystatin C stabilized against aggregation

Summary for 3GAX
Entry DOI10.2210/pdb3gax/pdb
Related1G96 1R4C 1TIJ
DescriptorCystatin-C (2 entities in total)
Functional Keywordscysteine protease inhibitor, 3d domain swapping, protein aggregation, amyloid, protein engineering, twinning, hereditary cystatin c amyloid angiopathy, amyloidosis, disease mutation, polymorphism, protease inhibitor, secreted, thiol protease inhibitor, hydrolase inhibitor
Biological sourceHomo sapiens (Human)
Cellular locationSecreted : P01034
Total number of polymer chains2
Total formula weight26802.43
Authors
Kolodziejczyk, R.,Michalska, K.,Hernandez-Santoyo, A.,Wahlbom, M.,Grubb, A.,Jaskolski, M. (deposition date: 2009-02-18, release date: 2010-02-23, Last modification date: 2023-09-06)
Primary citationKolodziejczyk, R.,Michalska, K.,Hernandez-Santoyo, A.,Wahlbom, M.,Grubb, A.,Jaskolski, M.
Crystal structure of human cystatin C stabilized against amyloid formation.
Febs J., 277:1726-1737, 2010
Cited by
PubMed Abstract: Human cystatin C (HCC) is a family 2 cystatin inhibitor of papain-like (C1) and legumain-related (C13) cysteine proteases. In pathophysiological processes, the nature of which is not understood, HCC is codeposited in the amyloid plaques of Alzheimer's disease or Down's syndrome. The amyloidogenic properties of HCC are greatly increased in a naturally occurring L68Q variant, resulting in fatal cerebral amyloid angiopathy in early adult life. In all crystal structures of cystatin C studied to date, the protein has been found to form 3D domain-swapped dimers, created through a conformational change of a beta-hairpin loop, L1, from the papain-binding epitope. We have created monomer-stabilized human cystatin C, with an engineered disulfide bond (L47C)-(G69C) between the structural elements that become separated upon domain swapping. The mutant has drastically reduced dimerization and fibril formation properties, but its inhibition of papain is unaltered. The structure confirms the success of the protein engineering experiment to abolish 3D domain swapping and, in consequence, amyloid fibril formation. It illustrates for the first time the fold of monomeric cystatin C and allows verification of earlier predictions based on the domain-swapped forms and on the structure of chicken cystatin. Importantly, the structure defines the so-far unknown conformation of loop L1, which is essential for the inhibition of papain-like cysteine proteases.
PubMed: 20175878
DOI: 10.1111/j.1742-4658.2010.07596.x
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.7 Å)
Structure validation

227111

PDB entries from 2024-11-06

PDB statisticsPDBj update infoContact PDBjnumon